ArticleJournal of attention disorders2023

Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate.

Judy van Stralen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.